FDAnews
www.fdanews.com/articles/203769-cepheid-gets-ce-mark-for-two-hiv-tests
CE mark

Cepheid Gets CE Mark for Two HIV Tests

August 2, 2021

Sunnyvale, Calif.-based Cepheid has received a CE mark for two HIV-1 tests: the Xpert HIV-1 Viral Load XC and Xpert HIV-1 Qual XC.

The tests can identify HIV viral load in new mothers and newborns to enable same-day treatment decisions, the company said.

Designed for use on Cepheid's GeneXpert Systems, which provide polymerase chain-reaction testing on location at medical centers and hospitals, can deliver results within 90 minutes.

View today's stories